Co-selection of cognate antibody-antigen pairs by selectively-infective phages  by Krebber, Claus et al.
FEBS 16419 FEBS Letters 377 (1995) 227-231 
Co-selection of cognate antibody-antigen pairs by 
selectively-infective phages 
Claus Krebber**, Stefania Spada**, Dominique Desplancq***, Andreas Pltickthun* 
Biochemisches Institut, Universitiit Ziirieh, Winterthurerst~ 190, CH-8057 Ziirieh, Switzerland 
Received 9November 1995 
Abstract We have developed a chloramphenicol resistant deriv- 
ative of fd phage with which cognate pairs of antibodies and 
antigens can be selected. The phage genome ncodes a fusion of 
single-chain antibody to the C-terminal domain of glIIp, render- 
ing the phage non-infective. The antigen fused to the N-terminal 
domains of glIIp is encoded in the same phage genome. Antigen 
and antibody fusion interact with each other in the periplasm of 
the phage-producing cell, restoring infectivity. This system has a 
very low background and will allow simultaneous randomisation 
of antibody and antigen. 
K~ y words: Selectively-infective phage; Phage display; 
Antibody engineering; Filamentous phage; Single-chain Fv 
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1. Introduction 
Phage display technology has been successfully used to select 
individual peptide or protein sequences that bind a given target 
from libraries of filamentous phages [1,2]. Applications of this 
technology have included determination of the peptide pitope 
ot an antibody [3] and selection for antibody fragments that 
bind to peptidic antigens [4]. We have now devised aselectively- 
in fective phage (SIP) in which cognate pairs of peptidic antigen 
arid antibody can be selected at the same time. 
In traditional phage panning, libraries of the peptide or pro- 
te~n of interest are fused to an intact gene III phage protein 
(gIIIp) [5] or to its C-terminal domain requiring the use of 
helper phages to supply wt glIIp [6]. The resulting display- 
phages are adsorbed to the binding partner and thus, either 
directly or indirectly, to a solid support. The major technical 
challenge is to separate phages bound by the cognate interac- 
ti,m from the great majority that are bound by nonspecific 
i~teractions. This is usually achieved by means of multiple 
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rounds of binding and subsequent reinfection. The nature of 
these experiments allows the randomisation of only one of the 
reaction partners. 
In our system, the antibody-displaying phage is itself non- 
infectious and acquires the ability to infect cells only upon the 
occurrence of a cognate interaction between antibody and anti- 
gen in the periplasm, directly liberating infectious phage from 
the host (Fig. 1). This selective infectivity is achieved by exploit- 
ing the modular structure of glIIp, a protein of three domains 
of 68, 131 and 150 amino acids separated by glycine-rich linkers 
of 18 and 39 amino acids, respectively (Fig. 2) [7]. The first two 
domains (N1-N2) have been shown to be responsible for the 
docking of the phage to the F-pili of male E. coli and subse- 
quent penetration of the bacterial membrane [8,9,10], while the 
C-terminal domain (CT) is presumed to have a structural role, 
making contact with the DNA and forming the tip of the phage 
particle [11]. 
It has previously been reported that phagemids can be used 
to display one of the interaction partners on the phage by fusing 
it to the N-terminus of the third domain ofglI lp (CT). Infection 
can then be restored by the addition of the first domain (N1) 
in vitro [12], or of the first two domains (N1-N2) in vivo [13], 
fused to the cognate partner. To package such phagemids a
second genetic entity, a helper phage, that provides the genes 
for all phage functions except he wt glIIp (AglIIHP), is needed 
[14,15]. 
In order to overcome the problems intrinsic to these AglIIHP 
(see below), we have engineered a single genetic package, a 
phage, which encodes both an antibody-CT fusion (scFv-CT) 
and a N1-N2-antigen fusion (N1-N2 Ag). This allows the for- 
mation of antibody-antigen complexes in the phage-producing 
cell, in the absence of any external factor, thus restoring phage 
infectivity. We have now developed a very stable phage vector 
system which does not undergo noticeable genetic rearrange- 
ment. We have therefore devised an extremely simple system, 
relying on the transmission of antibiotic resistance by phage 
infection of bacteria, for delineating pairs of interacting mole- 
cules in vivo. 
2. Materials and methods 
2.1. Bacteria, phages, plasmids 
XL1-Blue (Stratagene) (fecAl endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F" proAB laclqZAM15 TnlO (Tetr)] c) was used as donor. 
XL1-Blue MRF' Kan (Stratagene) (A(mcrA)183 A(mcrCB-hsdSMR- 
mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lae [F' proAB 
lacPZAM15 Tn5 (Kant)] c) was used as recipient, fd phage was obtained 
from American Type Culture Collection (ATCC: 15669-B2). Resist- 
ance genes were PCR-amplified from pACYC174 (camR), pACYC188 
(kan R) and pUC19 (ampR). 
2.2. scFv gene synthesis 
The single-chain Fv fragment (scFv) in the orientation V:linker-Vn 
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of the antibody 17/9 [16] was obtained by gene synthesis [17]. The VL 
domain carries a three amino acid long FLAG [18]. To eliminate any 
oligomerisation tendency of the scFv, we have used a 30 amino acid 
linker between the Vn and VL domains [19]. 
2.3. ELISA 
The hag-peptide KNSYPYDVPDYASLRS was synthesised on an 
ABI 430A Peptide Synthesizer (Applied Biosystems Inc.) using the 
FastMoc strategy [20]. The peptide was subsequently coupled to dena- 
tured and reduced transferrin by the heterobifunctional linker 3- 
maleimidobenzoyl-N-hydroxy-succinimide (Fluka) [21]. This was 
coated at 20/~g per well onto a Maxisorp ELISA plate (Nunc) at 4°C 
overnight. After 1 h blocking with 5% skim milk in PBS phage dilutions 
in PBS were incubated in the wells for 2 h at 26°C. The bound phages 
were detected with 1:5000 sheep anti-M13 IgG conjugated to horse- 
radish peroxidase (Pharmacia) with soluble substrate (Boehringer). 
2.4. Phage construction 
Cloning was carried out according to standard methods [22]. PCR 
was done with Vent-Polymerase (New England Biolabs) according to 
the manufacturer. 
2.5. Selective infection experiments 
An overnight culture of XL1-Blue, containing phage DNA, was used 
to inoculate 2× YT medium, supplemented with 1% glucose and antibi- 
otics (34 pg/ml cam, 5/lg/ml tet). Cells were grown at 37°C until an 
OD550 = 0.5 was reached. After centrifugation the pellet was resus- 
pended in 2 × YT medium containing the appropriate antibiotics and 
0.5 mM IPTG, to induce the expression of the two fusion proteins under 
the control of the lac promotors (lacP/°), allowing packaging of the 
phages. After overnight growth at 26°C, phage particles were harvested 
from the culture supernatant byprecipitation with polyethylene glycol 
and quantified by spectrophotometry [23]. To quantify infectivity, 
phages were incubated with 1 ml of XL 1-Blue MRF' Kan (OD550 = 0.5) 
for 1 h at 37°C with gentle agitation. Bacteria were plated on 2 x YT- 
agar containing 50/tg/ml kan, 34 pg/ml cam, 1% glucose. Phage clones 
were analysed either by restriction analysis of miniprep DNA or growth 
of the colonies in microtiter wells followed by ELISA testing of the 
phage-containing supernatants for antigen binding. 
3. Results and discussion 
Phage particles can in principle be produced by a phagemid/ 
helper phage system. In order to obtain a phage which is infec- 
tive only when a cognate interaction between antigen and anti- 
body takes place (SIP), the helper phage is not allowed to 
deliver any wt glII to the phage particles (AglII HP). This AglII 
HP must be able to infect a phagemid library, however, for 
which it needs gi l l  protein. This special helper phage must 
therefore be produced in a cell which harbours an unpackaga- 
ble glIIp expression plasmid [12,15]. In attempting to devise 
such a system, we found that all glIIp-expression plasmids 
tested, derived from pUC, pACYC or pBR vectors, were pack- 
aged with low efficiencies due to the presence of unidentified 
cryptic packaging signals (data not shown). This led to the 
production of wt glIIp in the pool of display phages, rendering 
Table 1 
Influence of different resistances on phage titer 
Phage Resistance Titer (pfu/ml) 
After 12 h growth After 20 h growth 
fCKC cam R 5 × 10 9 6 x 101° 
fCKK kan R 4 × 10 7 6 × 10 9 
fCKA amp R 4 × 10 I° 3 × 101° 
fd none 1012 1012 
Phages are derived from fd, with the antibiotic resistance genes inserted 
at the same point as shown in Fig. 3b for fCKC, but with the cam R 
replaced by kan a or amp R including their promoters. 
extrusion of phage particles outer membrane 
periplasm ~ ~ 
cytoplasmic membrane , 1 
cytoplasm ~ [ 
. . h~ / fd~ 
Fig. 1. The association of NI-N2-Ag, secreted to the periplasm, and 
scFv-CT, inserted in the inner membrane, occurs in the periplasm 
during phage assembly before extrusion. 
these infectious and thus losing the 'non-infectivity' which is the 
prerequisite for the selectivity of the infection process. This may 
also explain the background previously observed by other 
workers [12,15]. Alternatively, the phagemid library can be 
transformed into zlglII HP-containing cells [13]. Use of fCA55 
and fKN16 [14] gives rise, however to the assembly of 'stump' 
CT [14], competing with the display of antibody fusion on the 
phage. This will lead to varying, but always low, antibody 
display rates that are dependent on the differing folding effi- 
ciencies of scFvs [24]. Furthermore, in our experience AglII 
M13KO7, from which gi l l  is precisely deleted, showed high 
genetic instability and lowered the viability of bacteria (data not 
shown), making it difficult to use in the preparation of AglII 
M13KO7-containing competent cells to take up the phagemid 
library. 
In order to avoid these problems we attempted to simplify 
the system as much as possible by using a single genetic pack- 
age, incorporating the genes for both interaction partners in the 
same phage vector. The circular genome of the filamentous 
phages M13, fl and fd [25] consists of two transcription units, 
of 6 and 4 genes. The units are separated by a central terminator 
on one side and the origin of replication on the other (Fig. 3), 
and within the units there is no space between the open reading 
frames. 
We inserted an antibiotic resistance gene into the fd genome 
to facilitate detection of infection events because plaque forma- 
tion will occur only at near wt levels of replication and infectiv- 
ity. Since initial experiments using fd-tet phage [26], which 
carries a tetracycline r sistance gene in one of the hairpins of 
the phage origin of replication, yielded rather low phage titers, 
we decided to insert the resistance gene immediately down- 
stream from the central terminator (Fig. 3b). In the wt phage, 
the -35 box of the weak gi l l  promoter is within the end of 
gVIIl and the -10 box is within the strong central terminator 
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Fi;. 2. (a) wt fd phage is infective. (b) Multivalent antibody-displaying 
phge, devoid of N1-N2, is non-infective. (c) Infectivity is restored by 
th, cognate interaction between antibody and antigen, reconstituting 
lh~ glIIp functions. 
(ftlterm). Therefore, we duplicated the -35 promoter box in 
gVllI and inserted resistance cassettes between the duplicated 
a~eas (Fig. 3b). We tested several antibiotic resistances at this 
p~,sition and found that the phages remained highly infectious 
blLt showed different iters (Table 1) and plaque morphologies 
w~th different resistances. To optimise the expression level of 
tl~:e resistance gene, we randomised its -35 box promoter se- 
quence. Any sequence isolated from a plaque and then from 
b~dcterial colonies was reasoned to lead to a level of expression 
sufficiently low to be compatible with phage propagation but 
sufficiently high to provide resistance for selection (data not 
shown). All further experiments were then carried out with the 
cl~loramphenicol acetyl transferase gene (cam e) thus selected, 
a~ it, along with the fl-lactamase gene (amp R) gave the highest 
level of infectivity. Another advantage of cam R is that it does 
n~t give rise to growth of plasmid-free cells due to enzyme 
lcakage from the cells, as was observed in the case of amp R. 
In addition, the original gi l l  had to be replaced by the scFv- 
(F  fusion and the N1-N2-antigen fusion in order to make 
i~fectivity dependent on the interaction of the two gi l l  partners 
(l'igs. 1 and 2). In the first version, we opened gi l l  behind 
iX l-N2 at aa 256 (referring to the mature protein) and inserted 
tt,e DNA encoding the antigenic peptide in frame. This was 
fi,llowed by a Shine-Dalgarno sequence upstream of the single- 
cmin antibody gene, which was fused to the gil l  CT at aa 211 
(t:ig. 3c). In this orientation, however, homologous recombina- 
t~ 9n occurred at a very high frequency between the duplicated 
g ycine-rich regions, leading to restoration of a wt-like gill. 
qable 2 
I) ependence ofinfectivity on the combination ofscFv-CT with N 1-N2- 
Ag 
Piaage Input phage particles 
f-cFv-Ag scFv-CT N 1-N2-Ag 10 9 10 t° 1011 1012 
fl7/9-hag scl7/9-CT N1-N2-hag 13 228 ~103 ~104 
f-' D5-hag sc4D5-CT N1 -N2-hag 0 0 0 5 
f17/9 no Ag scl7/9-CT N1-N2 0 0 0 0 
Ix umber of colonies as a function of input phage particles. 
In the next version, therefore, we reversed the orientation of 
the gi l l  partners by placing scFv-CT upstream of N1-N2-Ag 
(Fig. 3d). The two fusions were expressed under the control of 
separate lac promoters (lacPZ°). Following removal of the origi- 
nal gill, the expression cassette was inserted irectly after the 
cam R and the newly-inserted hp terminator (hp ~erm) [27], and 
before the gil l  promoter (glII p) and fd term. Infectious phages 
with wt properties were again isolated. In this case wt glII was 
restored by intermolecular recombination, leading to duplica- 
tion of genes between the glycine-rich regions (Fig. 3d). 
In the third version of the system, we constructed a phage 
that does not rearrange at noticeable frequencies by almost 
completely eliminating the glycine-rich stretches. In the case of 
the scFv-CT, gi l l  was cut down to aa 250 and in case of 
N1-N2-Ag, to aa 219 (Fig. 3e). 
As a model system, we have used the well-characterised anti- 
body 17/9 which recognises the peptide epitope DVPDYA 
(hag) from hemagglutinin [16]. We tested the system by coex- 
pressing the cognate anti-HAG scFv 17/9 or the non-cognate 
anti-HER2 scFv 4D5 [24,28] with the N 1-N2-hag peptide fu- 
sion. We chose the antibody 4D5 as a control because we have 
found it to be extremely well expressed, and thus it should be 
displayed at a high level Any non-specific positive effect of 
scFv-CT on the infectivity of its phage particle will therefore 
favour the growth of the phage displaying the 4D5 antibody. 
Similar numbers of phages (109 1012) carrying cognate or 
non-cognate pairs of fusion proteins were used to infect cells. 
Of the 10 tl phage particles displaying anti-HAG scFv together 
with NI-N2 hag we obtained l03 colonies which acquired the 
resistance, whereas no resistant colonies were observed for the 
non-cognate anti-HER2 scFv (Table 2). Restriction analysis of 
twelve colonies gave rise to the expected pattern, indicating that 
no rearrangement had occurred. We conclude that a very selec- 
tive infection does indeed occur by the cognate antibody-anti- 
gen interaction, mediating the docking of probably several N 1- 
N2-hag proteins to the multivalent antibody-displaying phage. 
As a further control we deleted the epitope from N1 N2-Ag 
and, again, no infectivity was observed in 10 H phage particles. 
In a competitive experiment, only phages displaying anti-HAG 
scFv were isolated from a 1:100 mixture of anti-HAG to anti- 
HER2-carrying phages that co-expressed N1 N2-hag. Finally, 
under the conditions described, no background is observed 
(Table 3). 
Ongoing experiments explore the use of this system to ran- 
domise the epitope of 17/9 as well as to map permissible 
changes in the antibody. In this way we will be able to evaluate 
the limits of on-rate, off-rate and binding constant permissible 
for in vivo SIP. For non-peptidic antigens, we have also puri- 
fied the different N-terminal domains of glI lp and subse- 
quently chemically coupled these to several haptens. This will 
allow a more quantitative description of the infective process 
Table 3 
Competition between acognate and a non-cognate pair of gill fusions 
fl 7/9-hag: f4D5-hag fl 7/9-hag/total colonies 
mixture 1 1 : 10 60/60 
mixture 2 1 : 100 15/15 
Phages (Table 2) were mixed in different ratios before infection. All 
colonies obtained after infection were tested for the displayed scFv-CT 
fusion by their binding properties in functional ELISA. 
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Fig. 3. Organisation of the fd phage genome, magnified between gVIlI and gVI. glII-derived parts are grey. The domain structure is indicated by 
thick boxes, the glycine-rich linkers by thin boxes, terminators by hairpins, promoters by thin arrows. (a) wt. (b) fCKC indicating insertion site of 
antibiotic resistance. (c) Version 1 of the SIP system, leading to deletions between the two thick arrows reconstructing wtgill. (d) Version 2 of the 
SIP system leading to reconstruction f wt glII by duplication of the region between the white arrows. (e) Stable SIP system with glycine-rich domains 
eliminated, indicated by the arrows in (d). 
with respect o the N1-N2-Ag and N1-Ag fusions (C. Krebber 
et al., unpublished). 
Only those cells in which a cognate interaction mediates the 
binding of the two fusion proteins give rise to infectious phages. 
Since the phage genome carries the information for both the 
antigen and the antibody, selection can be carried out from a 
pool of either fusion protein. If pools of both partners are 
present, cognate pairs will be selected cooperatively in a co- 
evolutionary fashion. We believe that this system will be partic- 
ularly useful for simultaneously selecting antibodies against 
members of antigen libraries, e.g. cDNA libraries. Further- 
more, because of the simplicity of the system, mutagenesis of 
either partner can be carried through many generations. We 
foresee that the development of a continuous ystem will be 
achieved upon increasing the efficiency of the infection process 
through its mechanistic dissection. 
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